Skip to content
Use caution Drug recall · FDA · Published October 20, 2023

Glenmark Recalls Deferasirox Tablets Due to Failed Dissolution

Glenmark Pharmaceuticals recalls specific lots of Deferasirox Tablets for Oral Suspension, 500mg, because they failed dissolution specifications.

🇺🇸 FDA recall #D-0095-2024DrugGlenmark Pharmaceuticals ›
Take action

Contact the company

Recalling firmGlenmark Pharmaceuticals Inc., USA750 Corporate Dr · Mahwah, NJ 07430-2009
✎ GovInfoNow plain-language explainer

What happened, in plain English

Glenmark Pharmaceuticals Inc., USA is recalling Deferasirox Tablets for Oral Suspension, 500mg, in 30-count bottles due to failed dissolution specifications. The affected products were distributed nationwide in the USA. The recall covers specific lots with expiration dates ranging from December 2023 to August 2024. Read more at govinfonow.com/recall/33035-glenmark-recalls-deferasirox-tablets-due-to-failed-dissolution.

Source Summary by GovInfoNow · govinfonow.com/recall/33035-glenmark-recalls-deferasirox-tablets-due-to-failed-dissolution · Updated October 9, 2026 · FDA enforcement record: FDA #D-0095-2024

Cite this page

“Glenmark Recalls Deferasirox Tablets Due to Failed Dissolution.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/33035-glenmark-recalls-deferasirox-tablets-due-to-failed-dissolution. Based on FDA recall #D-0095-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0095-2024%22&limit=1).

Why it’s dangerous

The tablets failed dissolution specifications, which means the drug may not release or absorb properly in the body. This could result in the medication not working as intended to treat the patient's condition.

Who’s affected

Patients in the USA who have been prescribed Deferasirox Tablets for Oral Suspension, 500mg by Glenmark Pharmaceuticals. Individuals with prescriptions filled during the distribution period are most at risk of receiving affected lots.

How to tell if you have this one

Check your bottle for the brand Glenmark Pharmaceuticals and NDC 68462-496-30. Look for lot numbers 17220063, 17220396, 17220397, 17220965, 17221187, 17221523, 17221793, 17221794, or 17221801. Verify the expiration date is between 12/2023 and 08/2024.

  • Brand
    Glenmark Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your medication

    Verify if your bottle matches the recalled lot numbers and expiration dates listed in the recall record.

  2. Contact your pharmacist

    Speak with your pharmacy or healthcare provider to determine if you have a recalled product and to discuss replacement options.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 26 days after the firm started it.

1. Firm started the recall: Oct 20, 202312. FDA classified it Class II: Nov 8, 202323. Published in FDA’s Enforcement Report: Nov 15, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Glenmark Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0095-2024 (October 20, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0095-2024 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA